Does diagnostic lignocaine block have a therapeutic value in treatment of hypertonic pharyngoesophageal segment?
Desphande
Mandar
M
Department of Head and Neck Surgery, Tata Memorial Hospital, Parel, Mumbai, India.
Rao
Vishal
V
Chaukar
Devendra
D
Chaturvedi
Pankaj
P
Pai
Prathamesh
P
D'cruz
Anil
A
D000779:Anesthetics, Local; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D007822:Laryngeal Neoplasms / Q000601:surgery; D007825:Laryngectomy / Q000534:rehabilitation; D008012:Lidocaine; D009122:Muscle Hypertonia / Q000175:diagnosis* / Q000188:drug therapy*; D009407:Nerve Block; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D010699:Phonation / Q000187:drug effects; D013072:Speech, Esophageal / Q000379:methods*; D014833:Voice Quality / Q000187:drug effects
D000779:Anesthetics, Local; D009465:Neuromuscular Agents; D008012:Lidocaine; D019274:Botulinum Toxins, Type A